<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-890603845AGSNM</udiDi>
    <basicUdiDi>B-890603845AGSNM</basicUdiDi>
    <tradeName>SURGISPON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aegis Lifesciences Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000024058</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SSP, MSP, USP, BX, GS, SG, DS, ES, GSP, CL, HG, HSP, PS, OC, SZ, SDT, KDM, BDT, MDD, HY, RS, KD, TOP, MVG, IDT, PC, DSP,</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:33:39.213Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-890603845ORCQU</udiDi>
    <basicUdiDi>B-890603845ORCQU</basicUdiDi>
    <tradeName>Surgi-ORC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aegis Lifesciences Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000024058</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>CELLULOSE AND/OR MODIFIED CELLULOSE DRESSINGS, NON-COMBINED OR COMBINED WITH OTHER SUBSTANCES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SOO, SOK, SON, SOF</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:33:39.197Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-890603845PVAR9</udiDi>
    <basicUdiDi>B-890603845PVAR9</basicUdiDi>
    <tradeName>Surgi-PVA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aegis Lifesciences Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000024058</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EP, NP, ES, EYW, ED, LED, LER, ELS, CLS, IB, IW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:33:39.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-890603845AGSPJM</udiDi>
    <basicUdiDi>B-890603845AGSPJM</basicUdiDi>
    <tradeName>SURGISPON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aegis Lifesciences Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000024058</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-29T06:30:04.169Z</lastUpdated>
  </row>
</eudamedExport>